Ana João Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana João Santos has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ariadna Feliu
Department of Primary Care and Public Health, Imperial College London, London, UK
1 shared publication Ausenda Machado
Epidemiology Department, National Institute of Health Doctor Ricardo Jorge, Lisboa, Portugal
1 shared publicationCarlos Matias-Dias
Epidemiology Department, National Institute of Health Doctor Ricardo Jorge, Lisboa, Portugal
1 shared publication- Carolina Espina
Environmental and Lifestyle Epidemiology Branch, International Agency for Research on Cancer, Lyon, France
1 shared publication - Erica D´sOuza
Environmental and Lifestyle Epidemiology Branch, International Agency for Research on Cancer, Lyon, France
1 shared publication - Helena Sousa
RISE-Health, Department of Education and Psychology, University of Aveiro, Aveiro, Portugal
1 shared publication
Latest Publications
- Open Access
- 12 May 2026
- Published by Springer Nature in Archives of Public Health
- Vol. 84 (1)
Development and validation of an instrument to assess public perception of cancer primary prevention information
Cancer primary prevention (CPP), particularly through evidence-based recommendations like the 4th European Code Against Cancer (ECAC4), represents a cost-e
- 12 May 2026
- Published by Springer Nature in Archives of Public Health
- Vol. 84 (1)
Open AccessDevelopment and validation of an instrument to assess public perception of cancer primary prevention information
Cancer primary prevention (CPP), particularly through evidence-based recommendations like the 4th European Code Against Cancer (ECAC4), represents a cost-e
- Open Access
- 19 January 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1331136
Health beliefs and attitudes toward Influenza and COVID-19 vaccination in Portugal: a study using a mixed-method approach
Introduction: Vaccination is one of the most effective population strategies to prevent infectious diseases and mitigate pandemics, and it is important to understand vaccine uptake determinants since vaccine hesitancy has been increasing for the past few decades. The Health Belief Model (HBM) has been widely used for understanding vaccination behavior. The current study aimed to assess influenza vaccine (IV) non-uptake and attitudes toward COVID-19 vaccination, two important respiratory diseases with similar symptoms, and routes of transmission in the Portuguese population.Methods: We conducted a cross-sectional study using a panel sample of randomly chosen Portuguese households. A total of 1,050 individuals aged 18 years and over responded to a telephone or online questionnaire. Through a mixed-method approach, we employed thematic content analysis to describe reasons for not taking the IV, considering the HBM dimensions, and quantitative statistical analysis to estimate IV and COVID-19 vaccine coverage.Results: The IV uptake for the overall population was 30.7% (CI 95%: 26.5, 35.2). Susceptibility was found to be a main factor for IV non-uptake, followed by barriers, such as stock availability and fear of adverse effects. The uptake of the COVID-19 vaccine was very high in the study population (83.1%, CI 95%: 13.6%−20.9%). There was a high perception of COVID-19-associated severity and fear of the consequences. Individuals who reported IV uptake seemed to perceive a higher severity of COVID-19 and a higher benefit of taking the COVID-19 vaccine for severe complications.Discussion: Thus, the population does not seem to consider influenza to be a health risk, as opposed to COVID-19, which is considered to be a possibly severe disease. The association between IV uptake and COVID-19 perceptions highlights that an overall attitude toward vaccination in general may be an important individual determinant.
- 19 January 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1331136
Open AccessHealth beliefs and attitudes toward Influenza and COVID-19 vaccination in Portugal: a study using a mixed-method approach
Introduction: Vaccination is one of the most effective population strategies to prevent infectious diseases and mitigate pandemics, and it is important to understand vaccine uptake determinants since vaccine hesitancy has been increasing for the past few decades. The Health Belief Model (HBM) has been widely used for understanding vaccination behavior. The current study aimed to assess influenza vaccine (IV) non-uptake and attitudes toward COVID-19 vaccination, two important respiratory diseases with similar symptoms, and routes of transmission in the Portuguese population.Methods: We conducted a cross-sectional study using a panel sample of randomly chosen Portuguese households. A total of 1,050 individuals aged 18 years and over responded to a telephone or online questionnaire. Through a mixed-method approach, we employed thematic content analysis to describe reasons for not taking the IV, considering the HBM dimensions, and quantitative statistical analysis to estimate IV and COVID-19 vaccine coverage.Results: The IV uptake for the overall population was 30.7% (CI 95%: 26.5, 35.2). Susceptibility was found to be a main factor for IV non-uptake, followed by barriers, such as stock availability and fear of adverse effects. The uptake of the COVID-19 vaccine was very high in the study population (83.1%, CI 95%: 13.6%−20.9%). There was a high perception of COVID-19-associated severity and fear of the consequences. Individuals who reported IV uptake seemed to perceive a higher severity of COVID-19 and a higher benefit of taking the COVID-19 vaccine for severe complications.Discussion: Thus, the population does not seem to consider influenza to be a health risk, as opposed to COVID-19, which is considered to be a possibly severe disease. The association between IV uptake and COVID-19 perceptions highlights that an overall attitude toward vaccination in general may be an important individual determinant.